Genetics of lung cancer susceptibility and COPD

Slides:

Advertisements

Similar presentations

Ancient Endo-siRNA Pathways Reveal New Tricks Julie M. Claycomb Current Biology Volume 24, Issue 15, Pages R703-R715 (August 2014) DOI: /j.cub

Advertisements

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics

The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)

Primary microcephaly: do all roads lead to Rome? Gemma K. Thornton, C. Geoffrey Woods Trends in Genetics Volume 25, Issue 11, Pages (November 2009)

CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.

The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.

Association of heart diseases with COPD and restrictive lung function – Results from a population survey Berne Eriksson, Anne Lindberg, Hana Müllerova,

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Obstructive lung disease in children with mild to severe BPD Eva Berggren Broström, Per Thunqvist, Gunilla Adenfelt, Elisabeth Borling, Miriam Katz-Salamon.

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis.

Venezuela: violence, human rights, and health-care realities

Volume 390, Issue 10098, Pages (September 2017)

Pathogenesis of urinary tract infections with normal female anatomy

Pharmacogenetics and future drug development and delivery

Epidemiology and Treatment of Lung Cancer in Seattle

W.L. Coudon, M.D., J.O. Harris, M.D. CHEST

Copyright © 2015 by the American Osteopathic Association.

Thank God for Richard Dawkins?

Prevalence and outcome of lung cancer in lung transplant recipients

Long-term effects of hormone replacement therapy

Simple versus complex COPD: implications for health-care management

Infections related to totally implantable venous-access ports

Shireen Mirza, MBBS, Roberto Benzo, MD Mayo Clinic Proceedings

Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis Jean Joel Bigna, MD, Angeladine.

Long-term effects of hormone replacement therapy

Personalized Disease Models on a Chip

Aspirin in the prevention of cancer – Author's reply

Gene therapy—where are we?

Elucidating COPD pathogenesis by large-scale genetic analyses

Ana Victoria Roman, Wilton Perez, Richard Smith The Lancet

Electronic Updates for JTO Readers

Disease and stigma The Lancet Volume 354, (December 1999)

Ovarian cancer screening: UKCTOCS trial – Authors' reply

Informing NCD control efforts in India on the eve of Ayushman Bharat

HIV myths should not be resuscitated

Michael J Goldacre, Jenny J Maisonneuve The Lancet

Frank Detterbeck, MD Journal of Thoracic Oncology

Volume 380, Issue 9836, Pages (July 2012)

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Personalized Disease Models on a Chip

Confessions of a journal junkie

The wonders of the recurated Wellcome Collection

Telling it like it isn't: truth and lies in a post-9/11 world

Chronic obstructive pulmonary disease in non-smokers

Thank God for Richard Dawkins?

Erratum Journal of Thoracic Oncology

Low-technology approaches

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

PM2·5: an important cause for chronic obstructive pulmonary disease?

Inhaled triple therapy in chronic obstructive pulmonary disease

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

MTP13-01: Indications and limitations of bronchoscopy

GBD 2016 estimates problematic for South Africa

Infections related to totally implantable venous-access ports

Spatial lifecourse epidemiology

Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Non– Small-Cell Lung Cancer Seung Jun Lee, MD, Jinwoo Lee, MD, Young.

Genetic enhancement of radionuclide cancer therapy

A remarkable report card on progress in COPD

Ebola control: rapid diagnostic testing

Difficulties of surgery in the developing world: a personal view

Improving management of neonatal infections

European Lung Cancer Conference (ELCC) 2016 Organisation

Volume 1, Issue 2, Pages (July 2014)

Guidance on research integrity: no union in Europe

Living in colour—American children, race, and wellbeing

Decision-Making in Patients With Cancer and Kidney Disease

Epidemiology of Thymoma and Associated Malignancies

Symptom-based stratification of autoimmune diseases

Sickle cell disease: a new era

Autism, maths, and sex: the special triangle

Presentation transcript:

Genetics of lung cancer susceptibility and COPD RP Young, RJ Hopkins, C Etzel, R El-Zein The Lancet Oncology Volume 12, Issue 7, Pages 622-623 (July 2011) DOI: 10.1016/S1470-2045(11)70169-3 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure Overlap of chronic obstructive pulmonary disease and lung cancer in smokers In epidemiology studies of chronic smokers, spirometric testing shows that about 20% have chronic obstructive pulmonary disease (COPD).3 This approach gives three groups of chronic smokers for comparison: those with normal lung function, COPD, and lung cancer. Lung cancer cases are further subdivided according to COPD phenotype.3 The Lancet Oncology 2011 12, 622-623DOI: (10.1016/S1470-2045(11)70169-3) Copyright © 2011 Elsevier Ltd Terms and Conditions